Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Profit After Tax (2016 - 2025)

Marimed (MRMD) has disclosed Profit After Tax for 15 consecutive years, with -$4.7 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 43.75% to -$4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.5 million through Dec 2025, down 16.09% year-over-year, with the annual reading at -$14.5 million for FY2025, 16.18% down from the prior year.
  • Profit After Tax for Q4 2025 was -$4.7 million at Marimed, down from -$2.9 million in the prior quarter.
  • The five-year high for Profit After Tax was $7.5 million in Q2 2021, with the low at -$10.2 million in Q4 2023.
  • Average Profit After Tax over 5 years is -$1.1 million, with a median of -$1.2 million recorded in 2024.
  • The sharpest move saw Profit After Tax soared 717.2% in 2021, then crashed 320.5% in 2023.
  • Over 5 years, Profit After Tax stood at -$6.4 million in 2021, then soared by 172.04% to $4.6 million in 2022, then crashed by 320.5% to -$10.2 million in 2023, then grew by 18.32% to -$8.3 million in 2024, then surged by 43.75% to -$4.7 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$4.7 million, -$2.9 million, and -$1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.